CELYAD ONCOLOGY Stock 12.4% Up Before The Weekend
(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) jumping 12.4% to €0.42 on Friday while BEL 20 jumped 1.09% to €3,672.03. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead…